Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7798]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
NICE give go ahead for olaparib and enzalutamide, but not abiraterone
NICE give go ahead for olaparib and enzalutamide, but not abiraterone
Researchers discover new aspect of gene regulation and possible target for cancer drugs
Researchers discover new aspect of gene regulation and possible target for cancer drugs
SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B
SABCS 2015: Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B
Bone cancer researchers discover how to block, potentially treat osteosarcoma
Bone cancer researchers discover how to block, potentially treat osteosarcoma
Drugs prevent heart damage during breast cancer treatment, study shows
Drugs prevent heart damage during breast cancer treatment, study shows
SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer
SABCS 2015: Promising phase 1 results lead to phase 2 for ONT-380 in HER2 breast cancer
Monoclonal antibody increases disease-free survival in breast cancer
Monoclonal antibody increases disease-free survival in breast cancer
Blocking body's first immune response could reduce cancer spread
Blocking body's first immune response could reduce cancer spread
Drug shows potential as safe and effective for most prevalent form of adult leukaemia
Drug shows potential as safe and effective for most prevalent form of adult leukaemia
Cancer study identifies genes that stop onset of leukaemia
Cancer study identifies genes that stop onset of leukaemia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation